2.23 0.09 (4.21%) | 07-12 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 3.59 | 1-year : | 4.2 |
Resists | First : | 3.08 | Second : | 3.59 |
Pivot price | 2.32 ![]() |
|||
Supports | First : | 1.97 | Second : | 1.28 |
MAs | MA(5) : | 2.37 ![]() |
MA(20) : | 2.11 ![]() |
MA(100) : | 2.73 ![]() |
MA(250) : | 1.62 ![]() |
|
MACD | MACD : | 0.1 ![]() |
Signal : | 0.1 ![]() |
%K %D | K(14,3) : | 55.2 ![]() |
D(3) : | 58.5 ![]() |
RSI | RSI(14): 55.4 ![]() |
|||
52-week | High : | 5.26 | Low : | 0.22 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ JAN ] has closed below upper band by 44.0%. Bollinger Bands are 7.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 2.43 - 2.45 | 2.45 - 2.46 |
Low: | 2.24 - 2.25 | 2.25 - 2.27 |
Close: | 2.38 - 2.41 | 2.41 - 2.43 |
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Fri, 12 Jul 2024
JANONE CONFIRMS NAME CHANGE TO ALT5 SIGMA CORPORATION AND NEW TICKER SYMBOL TO ALTS - PR Newswire
Wed, 10 Jul 2024
JanOne Announces Plan to Enhance Stockholder Value Through Strategic Realignment - PR Newswire
Thu, 16 May 2024
JanOne Closes Acquisition of ALT 5 Sigma Inc., a Leading Next Generation Blockchain Fintech - PR Newswire
Thu, 16 May 2024
JanOne acquires blockchain fintech ALT 5 Sigma - Investing.com
Wed, 22 Mar 2023
JanOne Sells Legacy Business ARCA Recycling to Concentrate on Growing BioPharm Businesses - PR Newswire
Mon, 03 Oct 2022
El Paso residents who recycle energy-sucking appliance can get paid $70 - KFOX
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Industrials
|
|
Industry:
Waste Management
|
|
Shares Out | 12 (M) |
Shares Float | 9 (M) |
Held by Insiders | 0.9 (%) |
Held by Institutions | 5.3 (%) |
Shares Short | 165 (K) |
Shares Short P.Month | 139 (K) |
EPS | -4.41 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.57 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | -12.8 % |
Return on Equity (ttm) | -104.1 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.31 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -2 (M) |
Levered Free Cash Flow | 2 (M) |
PE Ratio | -0.55 |
PEG Ratio | 0 |
Price to Book value | -4.31 |
Price to Sales | 0 |
Price to Cash Flow | -19.43 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |